Europe Asparaginase Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Escherichia coli, Erwinia chrysanthemi, Pegylated, and Others), Application (Therapeutic, Food Processing, and Others), and End-use Industry (Healthcare and Food Manufacturing)

No. of Pages: 107    |    Report Code: BMIRE00027448    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Asparaginase Market

1.           Introduction  16

1.1         Study Scope. 16

1.2         The Insight Partners Research Report Guidance. 16

1.3         Market Segmentation. 18

1.3.1        Europe Asparaginase Market – By Type. 20

1.3.2        Europe Asparaginase Market – By Application. 20

1.3.3        Europe Asparaginase Market – By End-Use Industry. 20

1.3.4        Europe Asparaginase Market – By Country. 21

2.           Key Takeaways  22

3.        Research Methodology  25

3.1         Coverage. 26

3.2         Secondary Research. 26

3.3         Primary Research. 27

4.           Europe Asparaginase Market – Market Landscape  28

4.1         Overview.. 28

4.2         Europe PEST Analysis. 28

4.3         Experts Opinion. 30

5.           Europe Asparaginase Market – Key Market Dynamics  31

5.1         Market Drivers. 31

5.1.1        Surging Incidences of Leukemia and Increasing Usage Application. 31

5.1.2        Growth of the Pharmaceutical and Food Industry. 31

5.2         Market Restraints. 32

5.2.1        Side Effects Associated With Use of Asparaginase. 32

5.3         Market Opportunities. 32

5.3.1        New Product Launches and Approvals. 32

5.4         Future Trends. 33

5.4.1        Increase in R&D Activities and Investment by Market Players. 33

5.5         Impact Analysis. 34

6.           Asparaginase Market– Europe Analysis  35

6.1         Europe Asparaginase Market Revenue Forecasts and Analysis. 35

7.           Europe Asparaginase Market Analysis – By Type  37

7.1         Overview.. 37

7.2         By Type: Europe Market Revenue and Forecast Analysis (US$ Million) 37

7.2.1        Escherichia Coli 38

7.2.1.1          Overview.. 38

7.2.1.2          Escherichia coli Market Revenue and Forecast to 2028 (US$ Million) 38

7.2.2        Erwinia Chrysanthemi 39

7.2.2.1          Overview.. 39

7.2.2.2          Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million) 39

7.2.3        Pegylated. 40

7.2.3.1          Overview.. 40

7.2.3.2          Pegylated Market Revenue and Forecast to 2028 (US$ Million) 40

7.2.4        Others. 41

7.2.4.1          Overview.. 41

7.2.4.2          Others Market Revenue and Forecast to 2028 (US$ Million) 41

8.           Europe Asparaginase Market Analysis – By Application  42

8.1         Overview.. 42

8.2         By Application: Europe Market Revenue and Forecast Analysis (US$ Million) 42

8.2.1        Therapeutic. 43

8.2.1.1          Overview.. 43

8.2.1.2          Therapeutic Market Revenue and Forecast to 2028 (US$ Million) 43

8.2.1.3          Acute Lymphoblastic Leukaemia (ALL) 44

8.2.1.3.1          Acute lymphoblastic leukemia Market Revenue and Forecast to 2028 (US$ Million) 44

8.2.1.4          Lymphoblastic Lymphoma (LBL) 45

8.2.1.4.1          Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million) 45

8.2.1.5          Others. 46

8.2.1.5.1          Others Market Revenue and Forecast to 2028 (US$ Million) 46

8.2.2        Food Processing. 47

8.2.2.1          Overview.. 47

8.2.2.2          Food Processing Market Revenue and Forecast to 2028 (US$ Million) 47

8.2.3        Others. 48

8.2.3.1          Overview.. 48

8.2.3.2          Others Market Revenue and Forecast to 2028 (US$ Million) 48

9.           Europe Asparaginase Market Analysis – By End-use Industry  49

9.1         By End-Use: Europe Market Revenue and Forecast Analysis (US$ Million) 49

9.1.1        Healthcare. 50

9.1.1.1          Overview.. 50

9.1.1.2          Healthcare Market Revenue and Forecast to 2028 (US$ Million) 50

9.1.2        Food Manufacturing. 52

9.1.2.1          Overview.. 52

9.1.2.2          Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million) 52

10.        Europe Asparaginase Market – Country Analysis  53

10.1      Overview.. 53

10.1.1     Europe: Asparaginase Market, by Country, 2021 & 2028 (%) 55

10.1.1.1       Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 56

10.1.1.1.1       Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 56

10.1.1.1.2       Germany: Asparaginase Market, by Type, 2019–2028 (US$ Million) 57

10.1.1.1.3       Germany: Asparaginase Market, by Application, 2019–2028 (US$ Million) 58

10.1.1.1.3.1     Germany Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million) 58

10.1.1.1.4       Germany: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million) 59

10.1.1.2       UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 59

10.1.1.2.1       UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 60

10.1.1.2.2       UK: Asparaginase Market, by Type, 2019–2028 (US$ Million) 61

10.1.1.2.3       UK: Asparaginase Market, by Application, 2019–2028 (US$ Million) 61

10.1.1.2.3.1     UK Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million) 62

10.1.1.2.4       UK: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million) 62

10.1.1.3       France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 63

10.1.1.3.1       France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 63

10.1.1.3.2       France: Asparaginase Market, by Type, 2019–2028 (US$ Million) 64

10.1.1.3.3       France: Asparaginase Market, by Application, 2019–2028 (US$ Million) 64

10.1.1.3.3.1     France Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million) 65

10.1.1.3.4       France: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million) 65

10.1.1.4       Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 66

10.1.1.4.1       Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 66

10.1.1.4.2       Italy: Asparaginase Market, by Type, 2019–2028 (US$ Million) 67

10.1.1.4.3       Italy: Asparaginase Market, by Application, 2019–2028 (US$ Million) 67

10.1.1.4.3.1     Italy: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 68

10.1.1.4.4       Italy: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million) 68

10.1.1.5       Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 69

10.1.1.5.1       Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 69

10.1.1.5.2       Spain: Asparaginase Market, by Type, 2019–2028 (US$ Million) 70

10.1.1.5.3       Spain: Asparaginase Market, by Application, 2019–2028 (US$ Million) 70

10.1.1.5.3.1     Spain: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 71

10.1.1.5.4       Spain: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million) 71

10.1.1.6       Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 72

10.1.1.6.1       Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 72

10.1.1.6.2       Rest of Europe: Asparaginase Market, by Type, 2019–2028 (US$ Million) 73

10.1.1.6.3       Rest of Europe: Asparaginase Market, by Application, 2019–2028 (US$ Million) 74

10.1.1.6.3.1     Rest of Europe: Asparaginase Market, by Therapeutic Application, 2019–2028 (US$ Million) 74

10.1.1.6.4       Rest of Europe: Asparaginase Market, by End Use Industry, 2019–2028 (US$ Million) 75

11.        Industry Landscape  76

11.1      Overview.. 76

11.2      Inorganic Growth Strategies. 76

11.2.1     Overview.. 76

11.3      Organic Growth Strategies. 77

11.3.1     Overview.. 77

12.        Company Profiles  79

12.1      Servier Pharmaceuticals LLC. 79

12.1.1     Key Facts. 79

12.1.2     Business Description. 79

12.1.3     Products and Services. 80

12.1.4     Financial Overview.. 80

12.1.5     SWOT Analysis. 81

12.1.6     Key Developments. 82

12.2      Biovendor, LLC. 83

12.2.1     Key Facts. 83

12.2.2     Business Description. 83

12.2.3     Products and Services. 84

12.2.4     Financial Overview.. 84

12.2.5     SWOT Analysis. 84

12.2.6     Key Developments. 85

12.3      Creative Enzymes. 86

12.3.1     Key Facts. 86

12.3.2     Business Description. 86

12.3.3     Products and Services. 87

12.3.4     Financial Overview.. 87

12.3.5     SWOT Analysis. 88

12.3.6     Key Developments. 88

12.4      Taj Pharmaceuticals Limited. 89

12.4.1     Key Facts. 89

12.4.2     Business Description. 89

12.4.3     Products and Services. 90

12.4.4     Financial Overview.. 90

12.4.5     SWOT Analysis. 90

12.5      medac GMBH.. 91

12.5.1     Key Facts. 91

12.5.2     Business Description. 91

12.5.3     Products and Services. 92

12.5.4     Financial Overview.. 92

12.5.5     SWOT Analysis. 92

12.5.6     Key Developments. 93

12.6      Jazz Pharmaceuticals, Inc. 94

12.6.1     Key Facts. 94

12.6.2     Business Description. 94

12.6.3     Products and Services. 94

12.6.4     Financial Overview.. 95

12.6.5     SWOT Analysis. 97

12.6.6     Key Developments. 98

12.7      Changzhou Qianhong Biopharma Co Ltd. 99

12.7.1     Key Facts. 99

12.7.2     Business Description. 99

12.7.3     Products and Services. 99

12.7.4     Financial Overview.. 99

12.7.5     SWOT Analysis. 100

12.7.6     Key Developments. 100

12.8      Porton Biopharma. 101

12.8.1     Key Facts. 101

12.8.2     Business Description. 101

12.8.3     Products and Services. 101

12.8.4     Financial Overview.. 101

12.8.5     SWOT Analysis. 102

12.8.6     Key Developments. 102

12.9      United Biotech (P) Limited. 103

12.9.1     Key Facts. 103

12.9.2     Business Description. 103

12.9.3     Products and Services. 103

12.9.4     Financial Overview.. 103

12.9.5     SWOT Analysis. 104

12.9.6     Key Developments. 104

13.        Appendix  105

13.1      About The Insight Partners. 105

13.2      Glossary of Terms. 105

 

 

LIST OF TABLES

Table 1.             Europe Asparaginase Market– Revenue and Forecast to 2028 (US$ Mn) 36

Table 2.             Germany Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 57

Table 3.             Germany Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 58

Table 4.             Germany Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 58

Table 5.             Germany Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million) 59

Table 6.             UK Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 61

Table 7.             UK Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 61

Table 8.             UK Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 62

Table 9.             UK Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million) 62

Table 10.          France Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 64

Table 11.          France Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 64

Table 12.          France Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Million) 65

Table 13.          France Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million) 65

Table 14.          Italy Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 67

Table 15.          Italy Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 67

Table 16.          Italy Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million) 68

Table 17.          Italy Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million) 68

Table 18.          Spain Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 70

Table 19.          Spain Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 70

Table 20.          Spain Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million) 71

Table 21.          Spain Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million) 71

Table 22.          Rest of Europe Asparaginase Market, by Type – Revenue and Forecast to 2028 (US$ Million) 73

Table 23.          Rest of Europe Asparaginase Market, by Application – Revenue and Forecast to 2028 (US$ Million) 74

Table 24.          Rest of Europe Asparaginase Market, by Therapeutic Application – Revenue and Forecast to 2028 (USD Million) 74

Table 25.          Rest of Europe Asparaginase Market, by End Use Industry – Revenue and Forecast to 2028 (US$ Million) 75

Table 26.          Recent Inorganic Growth Strategies. 76

Table 27.          Recent Organic Growth Strategies. 78

Table 28.          Glossary of Terms. 105

 

 

LIST OF FIGURES

Figure 1.           Europe Asparaginase Market Segmentation. 18

Figure 2.           Europe Asparaginase Market Segmentation, by Country. 19

Figure 3.           Europe Asparaginase Market Overview. 22

Figure 4.           Europe Asparaginase Market, By Type. 23

Figure 5.           Europe Asparaginase Market, By Country. 24

Figure 7.           Europe: PEST Analysis. 29

Figure 8.           Experts Opinion. 30

Figure 9.           Europe Asparaginase Market Impact Analysis of Drivers and Restraints. 34

Figure 10.        Europe Asparaginase Market – Revenue Forecasts and Analysis. 35

Figure 11.        By Type: Europe Market Analysis and Forecast 2021 and 2028 (%) 37

Figure 12.        Europe Escherichia coli Market Revenue and Forecast to 2028 (US$ Million) 38

Figure 13.        Europe Erwinia Chrysanthemi Market Revenue and Forecast to 2028 (US$ Million) 39

Figure 14.        Europe Pegylated Market Revenue and Forecast to 2028 (US$ Million) 40

Figure 15.        Europe Others Market Revenue and Forecast to 2028 (US$ Million) 41

Figure 16.        By Application: Europe Market Analysis and Forecast 2021 and 2028 (%) 42

Figure 17.        Europe Therapeutic Market Revenue and Forecast to 2028 (US$ Million) 43

Figure 18.        Europe Acute Lymphoblastic Leukemia Market Revenue and Forecast to 2028 (US$ Million) 44

Figure 19.        Europe Lymphoblastic lymphoma Market Revenue and Forecast to 2028 (US$ Million) 45

Figure 20.        Europe Others Market Revenue and Forecast to 2028 (US$ Million) 46

Figure 21.        Europe Food Processing Market Revenue and Forecast to 2028 (US$ Million) 47

Figure 22.        Europe Others Market Revenue and Forecast to 2028 (US$ Million) 48

Figure 23.        By End-Use: Europe Market Analysis and Forecast 2021 and 2028 (%) 49

Figure 24.        Europe Healthcare Market Revenue and Forecast to 2028 (US$ Million) 51

Figure 25.        Europe Food Manufacturing Market Revenue and Forecast to 2028 (US$ Million) 52

Figure 26.        Europe: Asparaginase Market, by Key Country – Revenue (2021) (US$ Million) 54

Figure 27.        Germany: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 57

Figure 28.        UK: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 60

Figure 29.        France: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 63

Figure 30.        Italy: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 66

Figure 31.        Spain: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 69

Figure 32.        Rest of Europe: Asparaginase Market – Revenue and Forecast to 2028 (US$ Million) 73

 

The List of Companies - Europe Asparaginase Market

  1. Biovendor, LLC
  2. Changzhou Qianhong Biopharma Co Ltd
  3. Creative Enzymes
  4. Jazz Pharmaceuticals, Inc.
  5. medac GMBH
  6. Porton Biopharma
  7. Servier Pharmaceuticals LLC
  8. Taj Pharmaceuticals Limited    
  9. United Biotech (P) Limited